The count of diagnoses is doing two jobs at once, and only one of them is biological. Dog Aging Project owners report each year what a veterinarian has told them [3], so a dog's tally rises with disease and also with the frequency of veterinary contact. A closely watched dog with four detected problems can outrank a rarely seen dog with six undetected ones. That does not sink the finding, but it means the exposure variable is partly a measure of surveillance.
The design handles the most obvious confound head-on. Dogs that die are on average older, and older dogs have had longer to accumulate labels, so the team compared the health histories of dogs that had died against those still living while accounting for age at enrollment and how long each dog had been in the study [4]. The survival gap survived adjustment for age and size [2], which is the part that makes the number worth arguing about.
Direction of causation is harder, and the paper's own illustration runs both ways: osteoarthritis can make a dog less active and heavier, while extra weight raises the risk of osteoarthritis [11]. Creevy extends that logic to daily function, noting that a dog which cannot move comfortably may exercise less, drink less water, or have trouble getting outside [14], and that cancer affects multiple body systems as it spreads [14]. Excess weight, on the same account, both contributes to chronic disease and results from it [15]. Those loops are the proposed mechanism for conditions compounding rather than adding. They are also the reason a fifth diagnosis may be a symptom of decline as much as a cause of it.
The thing the doubling does not tell you is whether treating that fifth condition buys anything back. An observational association between a count and a hazard carries no information about what changes when you intervene, and Creevy calls the work a first step toward helping owners prioritise where their money and effort go [12].
Two absences in the announcement are worth noting. The Texas A&M summary gives no confidence interval, no absolute annual mortality rate, and no count of how many of the 50,000-plus dogs died, which is the denominator the estimate actually rests on [16]. And the published contrast is five-or-more against exactly one [2], so the shape of the curve in between is unstated: whether the second condition costs as much as the fifth is a different question with a different answer.
One more boundary. The human multimorbidity literature came in the door as Creevy's motivation for asking the question in dogs [6], not out the other end as a result. What has been shown here is that in a large volunteer cohort of pet dogs, disease burden tracks survival after age and size are accounted for [2] [3]. The clinical implication travels only as far as the species studied.
